In line with this notion, few studies aiming at GLI inhibition in pancreatic, bladder, and colon cancer supported an anti-oncogenic rather than a cancer-promoting function of the Hh/GLI pathway. The gene discussed is GLI1; the disease is malignant colon neoplasm.